首页> 美国卫生研究院文献>British Medical Journal >Value of prednisone in combination chemotherapy of stage IV Hodgkins disease. Report from the British National Lymphoma Investigation.

【2h】

Value of prednisone in combination chemotherapy of stage IV Hodgkins disease. Report from the British National Lymphoma Investigation.

机译：泼尼松在IV期霍奇金病联合化疗中的价值。英国国家淋巴瘤调查报告。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

A combination of mustine, vincristine (Oncovin), procarbazine, and prednisione (MOPP) and the same combination without prednisone (MOP) were compared in the treatment of stage IV Hodgkin's disease in a prospective randomized trial. The complete remission rates were 80% with MOPP and 44% with MOP; the difference was highly significant. Prednisone seems to be an important component of the MOPP combination in the management of stage IV Hodgkin's disease.

机译：在一项前瞻性随机试验中，比较了芥子碱，长春新碱（Oncovin），丙卡巴肼和强的松（MOPP）的组合以及不含强的松（MOP）的相同组合在IV期霍奇金病的治疗中的作用。 MOPP的完全缓解率为80％，MOP的完全缓解率为44％；差异非常显着。泼尼松似乎是MOPP联合治疗IV期霍奇金病的重要组成部分。

著录项

期刊名称 British Medical Journal
作者

展开▼
作者单位

展开▼
年(卷),期 1975(3),5980
年度 1975
页码 413–414
总页数 2
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. British National Lymphoma Investigation: pilot studies of neoadjuvant chemotherapy in clinical stage Ia and IIa Hodgkin's disease. [J] . Moody AM, Pratt J, Hudson GV, Clinical oncology . 2001,第4期

机译：英国国家淋巴瘤调查：临床Ia期和IIa期霍奇金病新辅助化疗的初步研究。
2. Comments on the value International Prognostic Score (IPS), stage IV and age over 45 years, for the outcome of advanced Hodgkin lymphoma in chemotherapy containing adriamycin. The experience of the Spanish Hodgkin Lymphoma Study Group [J] . Guisado-Vasco Pablo, Montalban Carlos, Garcia Juan F. British Journal of Haematology . 2017,第2期

机译：评论含有AdRiamycin的化疗晚期Hodgkin淋巴瘤的结果的国际预后评分（IPS），第四阶段和年龄超过45岁。西班牙霍奇金淋巴瘤研究组的经验
3. Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma. [J] . Hagenbeek A, Eghbali H, Monfardini S, Journal of Clinical Oncology . 2006,第10期

机译：在新诊断的III和IV期低度恶性非霍奇金淋巴瘤患者中，将氟达拉滨磷酸酯与环磷酰胺，长春新碱和泼尼松化疗进行的III期组间研究。
4. MRI vs. CT in tumour volume assessment in non-Hodgkin's lymphoma during chemotherapy [C] . Rossi M, Dastidar P, Pertovaara H, European conference on biomaterials;ESB 2010 . 2010

机译：MRI与CT对非霍奇金淋巴瘤化疗期间肿瘤体积的评估
5. Estimation of G-CSF effectiveness in reducing neutropenia hospitalization among Non-Hodgkin's Lymphoma (NHL) patients treated with anthracycline-based chemotherapy. [D] . Pan, Xiaoyun. 2010

机译：估计G-CSF在以蒽环类为基础的化学疗法治疗的非霍奇金淋巴瘤（NHL）患者中减少中性粒细胞减少症住院的有效性。
6. Selective peripheral blood eosinophilia associated with survival advantage in Hodgkins disease (BNLI Report No 31). British National Lymphoma Investigation. [O] . B Vaughan Hudson, D C Linch, E A Macintyre, 1987

机译：选择性外周血嗜酸性粒细胞增多与霍奇金病的生存优势相关（BNLI报告第31号）。英国国家淋巴瘤调查。
7. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation. [O] . 1975

机译：泼尼松在IV期霍奇金病联合化疗中的价值。英国国家淋巴瘤调查报告。

Value of prednisone in combination chemotherapy of stage IV Hodgkins disease. Report from the British National Lymphoma Investigation.

摘要

著录项

相似文献

相关主题

期刊订阅